|
Zebrafish Models of Cancer
|
ZIA BC 010549
|
$746,879
|
$149,376
|
Hickstein, Dennis
|
CCR (NCI)
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-31S1
|
$97,935
|
$5,876
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-32S1
|
$99,959
|
$5,998
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-32
|
$1,889,710
|
$113,383
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
Women's Health Study: Continued Follow-up
|
2R01CA047988-19A2
|
$848,006
|
$169,601
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
WHI Hormones and Gynecologic Cancers Study
|
ZIA CP010126 10538
|
$26,342
|
$13,171
|
Brinton, Louise
|
DCEG (NCI)
|
|
Vitamin D, Related Genes and Breast Cancer Risk
|
5R01CA098661-07
|
$983,933
|
$147,590
|
ZELENIUCH-JACQUOTTE, ANNE
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Vitamin D Pooling Project
|
ZIA CP010195 10436
|
$337,546
|
$54,007
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-26S1
|
$487,529
|
$14,626
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
VCU Minority-Based Community Clinical Oncology Program
|
2U10CA052784-20
|
$359,518
|
$10,786
|
ROBERTS, JOHN
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-20S1
|
$100,001
|
$3,000
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-20S2
|
$197,549
|
$5,926
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Vascular Leukocytes influence the tumor microenvironment
|
5R01CA124515-04
|
$303,810
|
$303,810
|
Conejo-Garcia, Jose
|
DARTMOUTH COLLEGE
|
|
Vascular Leukocytes Induce regulatory T cells (Treg) in Tumors
|
5R01CA116779-05
|
$271,456
|
$135,728
|
COUKOS, GEORGE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Validating Cancer Risk Models: a Pilot Study to Evaluate Cost-efficient Methods
|
1R03CA150136-01
|
$89,742
|
$44,871
|
Whittemore, Alice
|
STANFORD UNIVERSITY
|
|
VALIDATING AND TARGETING LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE-BETA IN CANCER
|
5R01CA131400-02
|
$346,525
|
$346,525
|
Springett, Gregory
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Vaccine and radiation for the therapy of human cancers
|
ZIA BC 010975
|
$311,687
|
$31,169
|
Hodge, James
|
CCR (NCI)
|
|
Vaccine and Drug Combination Therapy for Human Cancers
|
ZIA BC 010661
|
$363,635
|
$36,364
|
Hodge, James
|
CCR (NCI)
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-37S1
|
$101,020
|
$1,010
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-37S2
|
$148,912
|
$1,489
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-37
|
$4,795,480
|
$47,955
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UT M.D. Anderson Cancer Center
|
5U10CA045809-22
|
$2,399,682
|
$95,987
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Using mouse models to probe the relationship of oncogenesis to development and o
|
5U01CA105492-07
|
$688,149
|
$227,089
|
HOLLAND, ERIC
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-35S1
|
$99,949
|
$3,998
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-35S2
|
$73,975
|
$2,959
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-35S3
|
$98,980
|
$3,959
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
5P30CA014089-35
|
$6,464,088
|
$258,564
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Urine and Serum Biomarkers for Screening and Diagnosis of Ovarian Cancer
|
2R01CA108990-06
|
$322,540
|
$322,540
|
LOKSHIN, ANNA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-26
|
$1,751,531
|
$52,546
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-24S6
|
$1,444,105
|
$72,205
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-24S7
|
$98,815
|
$4,941
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of New Mexico Cancer Center Support
|
2P30CA118100-06
|
$2,035,899
|
$61,077
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-05S6
|
$99,994
|
$3,000
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-06S1
|
$39,736
|
$1,192
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-06S2
|
$100,055
|
$3,002
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-06S3
|
$199,946
|
$5,998
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-23S1
|
$100,000
|
$2,000
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-23
|
$5,994,681
|
$119,894
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Tumor-Associated Antigens in Early Stage Serous Carcinoma
|
5R01CA122581-05
|
$263,559
|
$263,559
|
Roden, Richard
|
JOHNS HOPKINS UNIVERSITY
|
|
Tumor Targeted Nanobins for the Treatment of Metastatic Breast and Ovarian Cancer
|
1U01CA151461-01
|
$461,174
|
$230,587
|
O'HALLORAN, THOMAS
|
NORTHWESTERN UNIVERSITY
|
|
Tumor Suppressor Protein, p53
|
ZIA BC 005599
|
$271,285
|
$135,643
|
Appella, Ettore
|
CCR (NCI)
|
|
Tumor Host Range Mutants of Polyoma and Their Targets
|
5R01CA092520-10
|
$646,176
|
$646,176
|
BENJAMIN, THOMAS
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
|
Tumor -Targeting Chemotherapeutic Agents
|
5R01CA103314-19
|
$323,606
|
$74,429
|
OJIMA, IWAO
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Treatment of Chemotherapy-Resistant Human Ovarian Cancer by Administration of CPE
|
5R01CA122728-03
|
$344,171
|
$344,171
|
SANTIN, ALESSANDRO
|
YALE UNIVERSITY
|
|
Translational Research in Cancer
|
3P30CA056036-11S1
|
$99,766
|
$2,993
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
5P30CA056036-11
|
$3,102,433
|
$93,073
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Transforming growth factor beta signaling pathways
|
5R01CA055536-19
|
$308,158
|
$77,040
|
HOWE, PHILIP
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Transformative personalized vascular disrupting cancer immunotherapy
|
1R01CA156695-01
|
|
$0
|
COUKOS, GEORGE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Trans-NIH Angiogenesis Core Facility
|
ZIC BC 010964
|
$651,875
|
$195,562
|
Cuttitta, Frank
|
CCR (NCI)
|
|
Training Program in Cancer Epidemiology
|
5T32CA009001-35
|
$755,458
|
$188,865
|
STAMPFER, MEIR
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
Total relevant funding to Ovarian Cancer for this search: $112,260,730
|